Colgate-Palmolive Company (CL) : Sarasin Partners Llp scooped up 279,367 additional shares in Colgate-Palmolive Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 14, 2016. The investment management firm now holds a total of 2,737,937 shares of Colgate-Palmolive Company which is valued at $203,976,307.Colgate-Palmolive Company makes up approximately 3.27% of Sarasin Partners Llp’s portfolio.
Other Hedge Funds, Including , First Manhattan Co reduced its stake in CL by selling 11,042 shares or 4.39% in the most recent quarter. The Hedge Fund company now holds 240,623 shares of CL which is valued at $17,926,414. Colgate-Palmolive Company makes up approx 0.11% of First Manhattan Co’s portfolio.Murphy Pohlad Asset Management reduced its stake in CL by selling 350 shares or 1.08% in the most recent quarter. The Hedge Fund company now holds 31,975 shares of CL which is valued at $2,381,178. Colgate-Palmolive Company makes up approx 1.72% of Murphy Pohlad Asset Management’s portfolio.Salem Capital Management Inc reduced its stake in CL by selling 200 shares or 1.32% in the most recent quarter. The Hedge Fund company now holds 14,950 shares of CL which is valued at $1,113,327. Colgate-Palmolive Company makes up approx 0.62% of Salem Capital Management Inc’s portfolio.Central Bank Trust Co reduced its stake in CL by selling 189 shares or 15.9% in the most recent quarter. The Hedge Fund company now holds 1,000 shares of CL which is valued at $74,470. Colgate-Palmolive Company makes up approx 0.02% of Central Bank Trust Co’s portfolio.
Colgate-Palmolive Company closed down -0.22 points or -0.29% at $74.5 with 26,75,831 shares getting traded on Monday. Post opening the session at $74.78, the shares hit an intraday low of $74.44 and an intraday high of $74.92 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Colgate-Palmolive Company reported $0.63 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.63. The company had revenue of $3762.00 million for the quarter, compared to analysts expectations of $3760.63 million. The company’s revenue was down -7.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.66 EPS.
Investors should note that on Jun 9, 2016, Colgate-Palmolive Company announced a cash dividend of $0.3900. The company’s management has announced Jul 20, 2016 as the ex-dividend date and fixed the record date on Jul 22, 2016. The payable date has been fixed on Aug 15, 2016.
Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Upgraded by Goldman to ” Neutral” on May 2, 2016. Company shares were Reiterated by UBS on Apr 29, 2016 to “Neutral”, Firm has raised the Price Target to $ 76 from a previous price target of $73 .
Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.